CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 1 filers reported holding CARDIOME PHARMA CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,227,000 | 0.0% | 528,913 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $1,227,000 | +62.7% | 528,913 | +8.7% | 0.00% | 0.0% |
| Q4 2017 | $754,000 | -13.9% | 486,613 | +18.3% | 0.00% | 0.0% |
| Q3 2017 | $876,000 | -44.7% | 411,413 | +17.3% | 0.00% | -50.0% |
| Q2 2017 | $1,585,000 | +107.7% | 350,713 | +38.4% | 0.00% | +100.0% |
| Q1 2017 | $763,000 | +28.7% | 253,413 | +17.9% | 0.00% | 0.0% |
| Q4 2016 | $593,000 | +16.5% | 215,013 | +32.2% | 0.00% | 0.0% |
| Q3 2016 | $509,000 | +10.2% | 162,613 | +80.3% | 0.00% | 0.0% |
| Q2 2016 | $462,000 | +73.0% | 90,213 | +38.1% | 0.00% | 0.0% |
| Q1 2016 | $267,000 | -47.1% | 65,313 | +5.0% | 0.00% | 0.0% |
| Q4 2015 | $505,000 | -10.1% | 62,213 | -6.6% | 0.00% | 0.0% |
| Q3 2015 | $562,000 | -34.8% | 66,613 | -27.3% | 0.00% | -50.0% |
| Q2 2015 | $862,000 | -4.1% | 91,647 | -5.6% | 0.00% | 0.0% |
| Q1 2015 | $899,000 | +26.1% | 97,113 | +25.9% | 0.00% | 0.0% |
| Q4 2014 | $713,000 | -5.1% | 77,113 | -8.3% | 0.00% | 0.0% |
| Q3 2014 | $751,000 | -33.2% | 84,113 | -41.3% | 0.00% | -33.3% |
| Q2 2014 | $1,125,000 | -35.5% | 143,298 | -35.0% | 0.00% | -25.0% |
| Q1 2014 | $1,745,000 | +27.9% | 220,613 | +0.8% | 0.00% | +33.3% |
| Q4 2013 | $1,364,000 | +83.3% | 218,913 | +4.2% | 0.00% | +50.0% |
| Q3 2013 | $744,000 | +90.8% | 210,113 | +5.2% | 0.00% | +100.0% |
| Q2 2013 | $390,000 | – | 199,813 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|